EMA401, an orally administered highly selective angiotensin II type 2 receptor antagonist, as a novel treatment for postherpetic neuralgia: a randomised, double-blind, placebo-controlled phase 2 clinical trial
| Autor: | Rice, Andrew S C, Dworkin, Robert H, McCarthy, Tom D, Anand, Praveen, Bountra, Chas, McCloud, Philip I, Hill, Julie, Cutter, Gary, Kitson, Geoff, Desem, Nuket, Raff, Milton |
|---|---|
| Zdroj: | In The Lancet 10-16 May 2014 383(9929):1637-1647 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|